These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11864808)

  • 1. Changes in brain functional homogeneity in subjects with Alzheimer's disease.
    Volkow ND; Zhu W; Felder CA; Mueller K; Welsh TF; Wang GJ; de Leon MJ
    Psychiatry Res; 2002 Feb; 114(1):39-50. PubMed ID: 11864808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
    Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
    Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
    Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients.
    Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Sakurai H; Iwamoto T
    J Neurol Sci; 2012 Dec; 323(1-2):71-6. PubMed ID: 22967747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
    Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography.
    Zahn R; Buechert M; Overmans J; Talazko J; Specht K; Ko CW; Thiel T; Kaufmann R; Dykierek P; Juengling F; Hüll M
    Psychiatry Res; 2005 Nov; 140(2):115-31. PubMed ID: 16253483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease.
    Mentis MJ; Weinstein EA; Horwitz B; McIntosh AR; Pietrini P; Alexander GE; Furey M; Murphy DG
    Biol Psychiatry; 1995 Oct; 38(7):438-49. PubMed ID: 8672604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
    Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.